FINEXTRA RESEARCH LIMITED
Company number 03903271 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: FINEXTRA RESEARCH LIMITED
1. Financial Health Score: B-
Explanation: The patient is in stable condition with positive vital signs, but shows concerning symptoms of cash depletion that require monitoring. The business has survived for over 24 years and maintains positive equity with no long-term debt, which are encouraging signs of resilience. However, the persistent decline in cash reserves and modest profitability suggest the business is not thriving—merely surviving. Like a patient with a chronic condition that is managed but not cured, Finextra needs ongoing attention to its cash flow health.
2. Key Vital Signs
Heart Rate — Cash Position
| Year | Cash | Year-on-Year Change |
|---|---|---|
| 2021 | £2,146,144 | — |
| 2022 | £1,683,684 | -21.5% |
| 2023 | £1,116,773 | -33.6% |
| 2024 | £773,151 | -30.8% |
Diagnosis: Arrhythmia detected. The cash position has declined by approximately £1.37 million over three years—a sustained hemorrhage averaging £457,000 per year. While £773,151 remains a reasonable cash balance for a company of this size, the trajectory is alarming. At this rate of depletion, the company would exhaust its cash reserves within approximately 20 months without intervention.
However, context is essential: some of this cash reduction may reflect deliberate actions such as paying down creditors (which decreased from £1,590,832 to £1,381,341) or potential dividend distributions.
Blood Pressure — Working Capital
| Metric | 2024 | 2023 |
|---|---|---|
| Current Assets | £2,002,229 | £2,185,603 |
| Current Liabilities | £1,381,341 | £1,590,832 |
| Net Current Assets | £620,888 | £594,771 |
| Current Ratio | 1.45:1 | 1.37:1 |
Diagnosis: Blood pressure within acceptable range. The current ratio of 1.45:1 indicates the company can meet its short-term obligations, and it has improved slightly from 1.37:1 in 2023. This is the financial equivalent of a patient whose circulatory system is functioning, but not with the robustness one would prefer. A ratio above 1.5:1 would provide more comfort.
Cholesterol — Debt Structure
| Metric | 2024 |
|---|---|
| Long-term Debt | £0 |
| Total Liabilities | £1,381,341 |
| Net Assets | £621,526 |
| Debt-to-Equity Ratio | 2.22:1 |
Diagnosis: Mixed results. The absence of long-term debt is excellent—this is a business that isn't relying on borrowed time. However, the debt-to-equity ratio of 2.22:1 indicates that liabilities are more than double the equity, which places pressure on the balance sheet. The good news is that the largest creditor component (£805,030 in accruals and deferred income) represents revenue already received for services yet to be delivered—this is essentially pre-paid revenue rather than traditional debt.
Body Mass Index — Asset Composition
| Asset Category | 2024 | % of Total |
|---|---|---|
| Trade Debtors | £934,045 | 46.7% |
| Cash | £773,151 | 38.6% |
| Prepayments | £278,678 | 13.9% |
| Other Debtors | £16,355 | 0.8% |
| Tangible Fixed Assets | £851 | 0.04% |
| Total | £2,002,229 | 100% |
Diagnosis: Lightweight but potentially fragile. This is an asset-light digital media business—nearly all value is in receivables and cash rather than physical assets. The significant concentration in trade debtors (46.7% of total assets) is a vulnerability. If collections slow or debts become impaired, the financial health could deteriorate rapidly. Trade debtors increased by 7.6% from £868,440 to £934,045, which could indicate either revenue growth or slower collection.
Temperature — Profitability Indicator
| Year | P&L Reserves | Implied Annual Profit |
|---|---|---|
| 2023 | £590,971 | — |
| 2024 | £617,726 | £26,755 |
Diagnosis: Low-grade fever. The modest increase in retained profits of £26,755 suggests thin margins. For a company with 21 employees and over £2 million in assets, this level of profitability is underwhelming. However, this figure may not tell the complete story—dividend payments, corporation tax (£28,312), and other distributions would reduce retained profits regardless of operating performance.
Immune System — Balance Sheet Resilience
| Metric | Value | Assessment |
|---|---|---|
| Net Assets | £621,526 | Positive equity ✓ |
| Share Capital + Reserves | £621,526 | Fully funded ✓ |
| Capital Redemption Reserve | £1,374 | Minimal buffer |
| Going Concern Status | Affirmed | ✓ |
Diagnosis: Functional immune system but limited reserves. The company has positive net assets and directors have affirmed going concern status. The capital redemption reserve of £1,374 is negligible, and the share capital of just £2,426 (2,426 shares of £1 each) represents an extremely thin capital base. The company's resilience depends almost entirely on accumulated retained profits rather than paid-in capital.
3. Diagnosis
Overall Financial Condition: Stable but Under Observation
Primary Condition: Chronic Cash Depletion Syndrome
The most significant finding is the sustained erosion of cash reserves from £2.15 million (2021) to £773,151 (2024). This represents a 64% decline over three years. While the company remains solvent and operational, this trajectory, if continued, would become critical within 18-24 months.
Secondary Conditions:
-
Trade Debtor Dependency: With 46.7% of total assets tied up in trade debtors, the company's financial health is heavily dependent on timely customer payments. Any deterioration in collection rates would immediately impact liquidity.
-
Deferred Income Obligations: The £805,030 in accruals and deferred income represents a significant commitment to deliver future services. While this is normal for subscription-based media businesses, it means the company has already "spent" a portion of its apparent asset base.
-
Thin Profitability: The implied profit of approximately £26,755 (before potential dividends) suggests the core business model generates modest returns relative to the asset base and employee count.
-
Asset Contraction: Total assets have declined from £2.88 million (2021) to £2.00 million (2024), a 30.5% reduction. While some contraction is expected as cash is deployed, the scale is notable.
Positive Indicators:
-
No Long-term Debt: The company operates without long-term borrowing, eliminating interest expense and refinancing risk.
-
Improving Working Capital: Net current assets increased from £594,771 to £620,888, and the current ratio improved.
-
Employee Growth: Staff numbers increased from 18 to 21, suggesting management confidence in the business outlook.
-
Established Business: Operating since 2000, the company has weathered multiple economic cycles.
-
Liability Reduction: Total liabilities decreased by £209,491 (13.2%) from 2023 to 2024, indicating active debt management.
4. Recommendations
Immediate Actions (0-3 months)
- Cash Flow Stabilization Protocol: Conduct a detailed cash flow forecast to understand the drivers of cash depletion. Determine how much is attributable to: - Operating losses - Debt repayment - Capital expenditure - Dividend distributions
Like a patient monitoring their fluid intake and output, the company needs to track exactly where cash is going.
-
Trade Debtor Health Check: With £934,045 outstanding, implement a rigorous aged debtor analysis and collection protocol. Consider: - Tightening credit terms - Offering early payment discounts - Implementing automated follow-up systems - Reviewing credit policies for new customers
-
Deferred Income Management: Review the £805,030 in deferred income to ensure service delivery obligations are being met efficiently and revenue recognition is optimized.
Medium-Term Actions (3-12 months)
-
Revenue Enhancement: Given the thin margins, explore opportunities to: - Increase subscription rates (if market position allows) - Develop premium content tiers - Expand event or conference revenue - Monetize data or analytics products
-
Cost Structure Review: With 21 employees and modest profitability, conduct a thorough review of the cost base to identify: - Operational efficiencies - Technology automation opportunities - Outsourcing potential for non-core functions - Overhead reduction possibilities
-
Working Capital Optimization: Target a current ratio of 1.5:1 or above by: - Accelerating debtor collection - Negotiating extended payment terms with suppliers - Managing cash conversion cycle more actively
Long-Term Strategic Considerations (12+ months)
-
Capital Structure Review: The minimal share capital (£2,426) and reliance on retained profits creates vulnerability. Consider: - Whether the current capital structure supports strategic growth - Whether parent company Communify On Demand Ltd provides financial backing or creates financial dependency
-
Business Model Resilience: As a digital publishing business dependent on advertising and subscription revenue, ensure the business model can withstand: - Economic downturns affecting advertising spend - Competitive pressure from free content providers - Technology disruption in financial services media
-
Contingency Planning: Develop scenarios for: - Extended cash burn at current rates - Loss of major clients or advertising contracts - Economic recession impact on financial services sector spending
Monitoring Schedule
| Vital Sign | Frequency | Alert Threshold |
|---|---|---|
| Cash Position | Monthly | Below £500,000 |
| Trade Debtor Days | Monthly | Exceeding 60 days |
| Current Ratio | Quarterly | Below 1.2:1 |
| Profitability | Quarterly | Net loss for 2 consecutive quarters |
| Employee Costs vs. Revenue | Quarterly | Costs exceeding 70% of revenue |
Risk Assessment
| Risk Factor | Severity | Likelihood | Impact |
|---|---|---|---|
| Cash depletion continues | High | Medium | Critical |
| Major debtor default | Medium | Low | High |
| Revenue decline | Medium | Medium | High |
| Loss of key personnel | Medium | Low | Medium |
| Increased competition | Medium | High | Medium |